Relationship between the cholesterol ester transfer protein TaqIB polymorphism and the lipid-lowering effect of atorvastatin in patients with coronary atherosclerotic heart disease

Genetics and Molecular Research

Volumn 13, Issue 1, 2014, Pages 2140-2148

  Li, J ^a   Zhang, L ^a   Xie, N Z ^a   Deng, B ^b   Lv, L X ^a   Zheng, L Q ^a  

^a TONGJI UNIVERSITY   (China)

^b LONGHUA HOSPITAL AFFILIATED TO SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Atorvastatin; Cholesterol ester transfer protein; Coronary artery disease; Gene

Indexed keywords

ATORVASTATIN; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CETP GENE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DNA POLYMORPHISM; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN CELL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ALLELES; CHOLESTEROL ESTER TRANSFER PROTEINS; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPIDS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PYRROLES; TREATMENT OUTCOME;

EID: 84897942883     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.March.24.21     Document Type: Article

References (25)

1. Boekholdt SM and Thompson JF (2003). Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease. J. Lipid Res. 44: 1080-1093.
2. Boekholdt SM, Sacks FM, Jukema JW, Shepherd J, et al. (2005). Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13, 677 subjects. Circulation 111: 278-287.
3. Corbex M, Poirier O, Fumeron F, Betoulle D, et al. (2000). Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction. Genet. Epidemiol. 19: 64-80.
4. Estévez-González MD, Saavedra-Santana P, López-Ríos L, Chirino R, et al. (2010). HDL cholesterol levels in children with mild hypercholesterolemia: effect of consuming skim milk enriched with olive oil and modulation by the TAQ 1B polymorphism in the CETP gene. Ann. Nutr. Metab. 56: 288-293.
5. Ghasabeh TH, Firoozrai M, Zonouz AE, Radmehr H, et al. (2007). One common polymorphism of cholesteryl ester transfer protein gene in Iranian subjects with and without primary hypertriglyceridemia. Pak. J. Biol. Sci. 10: 4224-4229.
6. Hassanzadeh T, Firoozrai M, Zonouz AE, Zavarehee A, et al. (2009). Taq1B polymorphism of cholesteryl ester transfer protein (CETP) gene in primary combined hyperlipidaemia. Indian J. Med. Res. 129: 293-298.
7. Hokanson JE, Brunzell JD, Jarvik GP, Wijsman EM, et al. (1999). Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency. Am. J. Hum. Genet. 64: 608-618.
8. Hsieh MC, Tien KJ, Chang SJ, Lo CS, et al. (2007). Cholesteryl ester transfer protein B1B1 genotype as a predictor of coronary artery disease in Taiwanese with type 2 diabetes mellitus. Metabolism 56: 745-750.
9. Huang Y, Wu Y, Liu R, Fan P, et al. (2011). Differential effect of ATP binding cassette transporter A1 R219K and cholesteryl ester transfer protein TaqIB genotypes on HDL-C levels in overweight/obese and non-obese Chinese subjects. Acta Cardiol. 66: 231-237.
10. Kimura A (2009). Does a gene polymorphism predisposing to an intermediate phenotype predict the risk of disease? A lesson from CETP, high-density lipoprotein-cholesterol and coronary heart disease. Circ. J. 73: 1016-1017.
11. Kimura H, Miyazaki R, Imura T, Masunaga S, et al. (2011). Smaller low-density lipoprotein size as a possible risk factor for the prevalence of coronary artery diseases in haemodialysis patients: associations of cholesteryl ester transfer protein and the hepatic lipase gene polymorphism with low-density lipoprotein size. Nephrology 16: 558-566.
12. Kolovou G, Vasiliadis I, Kolovou V, Karakosta A, et al. (2011). The role of common variants of the cholesteryl ester transfer protein gene in left main coronary artery disease. Lipids Health Dis. 10: 156.
13. Krauss RM (2001). Dietary and genetic effects on low-density lipoprotein heterogeneity. Annu. Rev. Nutr. 21: 283-295.
14. Kuivenhoven JA, Jukema JW, Zwinderman AH, de Knijff P, et al. (1998). The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The regression growth evaluation statin study group. N. Engl. J. Med. 338: 86-93.
15. Lemieux I, Pascot A, Dumont M and Brochu M (2000). Is the high triglyceride-low HDL cholesterol atherogenic dyslipidemia a small, dense LDL or HDL phenotype? Atherosclerosis 151: 98-102.
16. López-Ríos L, Pérez-Jiménez P, Martínez-Quintana E, Rodriguez GG, et al. (2011). Association of Taq1B CETP polymorphism with insulin and HOMA levels in the population of the Canary Islands. Nutr. Metab. Cardiovasc. Dis. 21: 18-24.
17. Pillois X, Phuong Do TN, Reynaud A, Benchimol D, et al. (2009). TaqIB polymorphism in cholesterol ester transfer protein (CETP) gene predicts future cardiovascular death in patients experiencing an acute coronary syndrome. Clin. Chem. Lab. Med. 47: 1039-1046.
18. Rajman I, Kendall MJ, Cramb R, Holder RL, et al. (1996). Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic men. Atherosclerosis 125: 231-242.
19. Ranjith N, Pegoraro RJ and Rom L (2009). Lipid profiles and associated gene polymorphisms in young Asian Indian patients with acute myocardial infarction and the metabolic syndrome. Metab. Syndr. Relat. Disord. 7: 571-578.
20. Stancáková A, Baldaufová L, Javorský M, Kozárová M, et al. (2006). Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome. Physiol. Res. 55: 483-490.
21. Tsujita Y, Nakamura Y, Zhang Q, Tamaki S, et al. (2007). The association between high-density lipoprotein cholesterol level and cholesteryl ester transfer protein TaqIB gene polymorphism is influenced by alcohol drinking in a population-based sample. Atherosclerosis 191: 199-205.
22. Wu Y, Bai H, Liu R, Liu Y, et al. (2006). Analysis of cholesterol ester transfer protein gene TaqIB and-629 C/A polymorphisms in patients with endogenous hypertriglyceridemia in Chinese population. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 23: 640-646.
23. Yijiang Z, Ruixing Y, Yiyang L, Yaju D, et al. (2008). Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with serum lipid levels in the Guangxi Hei Yi Zhuang and Han populations. J. Investig. Med. 56: 847-857.
24. Yilmaz H, Isbir T, Agachan B and Karaali ZE (2005). Effects of cholesterol ester transfer protein Taq1B gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients. Cell Biochem. Funct. 23: 23-28.
25. Xu ZH, Guo HW and Huang ZY (2006). Effects of cholesterol ester transfer protein Taq1B polymorphism on response of serum HDL-C to dietary factors in hyperlipidemia patients. Zhonghua Yu Fang Yi Xue Za Zhi. 40: 269-272.